首頁 > 市場調查報告書 > 製藥

疼痛

全球控釋大麻丸市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

市場調查報告書

商品編碼

1421093

全球控釋大麻丸市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Controlled Release Cannabis Pills Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年01月01日 | 出版商:

Value Market Research | 英文 134 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球控釋大麻丸市場需求預計將從 2023 年的 112.2 億美元達到 2032 年近 152.3 億美元的市場規模，2024 - 2032 年研究期間CAGR為 3.45%。

控釋大麻丸通常是指含有大麻素（大麻中發現的活性化合物）的口服藥物製劑，旨在提供藥物在體內的受控和持續釋放。這些製劑旨在長期調節大麻素的釋放，與傳統的速釋製劑相比，提供更漸進和更持久的治療效果。

市場動態

控釋大麻丸市場是由醫用大麻和製藥創新交叉因素所驅動的。大麻素的治療潛力，特別是在治療慢性疾病方面，刺激了對提供穩定和延長釋放的控釋製劑的需求。患者的便利性和依從性的提高是重要的促進因素，因為控釋藥物提供了更方便的給藥選擇。標準化配方符合監管要求，提高了醫藥市場對大麻藥物的接受度。劑量的精確性允許客製化治療計劃，最佳化治療結果。藥物傳遞技術的進步有助於複雜製劑的開發。隨著醫用大麻市場的不斷擴大和持續的研究投資，控釋大麻藥丸代表了藥物中不斷成長的部分，以滿足患者對口服給藥的偏好。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球控釋大麻藥丸市場的每個細分市場進行了包容性評估。控釋大麻藥丸產業的成長和趨勢為本研究提供了整體方法。

市場區隔

控釋大麻藥丸市場報告的這一部分提供了國家和區域一級細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按產品分類

高 THC 膠囊
THC/CBD 平衡膠囊
高 CBD 膠囊

按最終用途

醫院藥房
零售藥局
藥局
網上銷售

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的控釋大麻丸市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。控釋大麻丸市場的主要參與者包括 Cannabics Pharmaceuticals 、 Wana Edibles 、 Depomed 、 Corium International Inc . 、 Collegium Pharmaceutical 、 GlaxoSmithKline 。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：大麻控釋丸公司的競爭格局

控釋大麻丸市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Cannabics Pharmaceuticals

公司簡介
公司收入
產品
最近的發展

Wana Edibles

公司簡介
公司收入
產品
最近的發展

Depomed

公司簡介
公司收入
產品
最近的發展

Corium International Inc.

公司簡介
公司收入
產品
最近的發展

Collegium Pharmaceutical

公司簡介
公司收入
產品
最近的發展

GlaxoSmithKline

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112113494

The global demand for Controlled Release Cannabis Pills Market is presumed to reach the market size of nearly USD 15.23 Billion by 2032 from USD 11.22 Billion in 2023 with a CAGR of 3.45% under the study period 2024 - 2032.

Controlled Release Cannabis Pills typically refer to oral pharmaceutical formulations containing cannabinoids, the active compounds found in cannabis, that are designed to provide a controlled and sustained release of the drug within the body. These formulations aim to regulate the release of cannabinoids over an extended period, offering a more gradual and prolonged therapeutic effect compared to traditional immediate-release formulations.

MARKET DYNAMICS

The Controlled Release Cannabis Pills market, is driven by factors at the intersection of medical cannabis and pharmaceutical innovations. The therapeutic potential of cannabinoids, especially in managing chronic conditions, fuels demand for controlled-release formulations offering steady and prolonged release. Patient convenience and improved adherence are significant drivers, as controlled-release pills provide a more convenient dosing option. Standardized formulations align with regulatory requirements, enhancing the acceptance of cannabis-based medications in pharmaceutical markets. The precision in dosing allows tailored treatment plans, optimizing therapeutic outcomes. Advances in drug delivery technologies contribute to the development of sophisticated formulations. With the expanding medical cannabis market and ongoing research investments, controlled release cannabis pills represent a growing segment in pharmaceuticals, catering to patient preferences for oral delivery.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of controlled release cannabis pills. The growth and trends of controlled release cannabis pills industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the controlled release cannabis pills market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

High THC Capsule
THC/CBD Balanced Capsules
High CBD Capsules

By End-Use

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Sales

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Controlled Release Cannabis Pills market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Controlled Release Cannabis Pills market include Cannabics Pharmaceuticals, Wana Edibles, Depomed, Corium International Inc., Collegium Pharmaceutical, GlaxoSmithKline. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . CONTROLLED RELEASE CANNABIS PILLS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By End-Use
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CONTROLLED RELEASE CANNABIS PILLS MARKET ANALYSIS BY PRODUCT

5.1 Overview by Product
5.2 Historical and Forecast Data
5.3 Analysis by Product
5.4 High THC Capsule Historic and Forecast Sales by Regions
5.5 THC/CBD Balanced Capsules Historic and Forecast Sales by Regions
5.6 High CBD Capsules Historic and Forecast Sales by Regions

6 . GLOBAL CONTROLLED RELEASE CANNABIS PILLS MARKET ANALYSIS BY END-USE

6.1 Overview by End-Use
6.2 Historical and Forecast Data
6.3 Analysis by End-Use
6.4 Hospital Pharmacies Historic and Forecast Sales by Regions
6.5 Retail Pharmacies Historic and Forecast Sales by Regions
6.6 Drug Stores Historic and Forecast Sales by Regions
6.7 Online Sales Historic and Forecast Sales by Regions

7 . GLOBAL CONTROLLED RELEASE CANNABIS PILLS MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1. Overview, Historic and Forecast Data Sales Analysis
- 7.3.2. North America By Segment Sales Analysis
- 7.3.3. North America By Country Sales Analysis
- 7.3.4. United State Sales Analysis
- 7.3.5. Canada Sales Analysis
- 7.3.6. Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1. Overview, Historic and Forecast Data Sales Analysis
- 7.4.2. Europe by Segment Sales Analysis
- 7.4.3. Europe by Country Sales Analysis
- 7.4.4. United Kingdom Sales Analysis
- 7.4.5. France Sales Analysis
- 7.4.6. Germany Sales Analysis
- 7.4.7. Italy Sales Analysis
- 7.4.8. Russia Sales Analysis
- 7.4.9. Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1. Overview, Historic and Forecast Data Sales Analysis
- 7.5.2. Asia Pacific by Segment Sales Analysis
- 7.5.3. Asia Pacific by Country Sales Analysis
- 7.5.4. China Sales Analysis
- 7.5.5. India Sales Analysis
- 7.5.6. Japan Sales Analysis
- 7.5.7. South Korea Sales Analysis
- 7.5.8. Australia Sales Analysis
- 7.5.9. South East Asia Sales Analysis
- 7.5.10. Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1. Overview, Historic and Forecast Data Sales Analysis
- 7.6.2. Latin America by Segment Sales Analysis
- 7.6.3. Latin America by Country Sales Analysis
- 7.6.4. Brazil Sales Analysis
- 7.6.5. Argentina Sales Analysis
- 7.6.6. Peru Sales Analysis
- 7.6.7. Chile Sales Analysis
- 7.6.8. Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1. Overview, Historic and Forecast Data Sales Analysis
- 7.7.2. Middle East & Africa by Segment Sales Analysis
- 7.7.3. Middle East & Africa by Country Sales Analysis
- 7.7.4. Saudi Arabia Sales Analysis
- 7.7.5. UAE Sales Analysis
- 7.7.6. Israel Sales Analysis
- 7.7.7. South Africa Sales Analysis
- 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE CONTROLLED RELEASE CANNABIS PILLS COMPANIES

8.1. Controlled Release Cannabis Pills Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9 . COMPANY PROFILES OF CONTROLLED RELEASE CANNABIS PILLS INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Cannabics Pharmaceuticals
- 9.3.1. Company Overview
- 9.3.2. Company Revenue
- 9.3.3. Products
- 9.3.4. Recent Developments
9.4. Wana Edibles
- 9.4.1. Company Overview
- 9.4.2. Company Revenue
- 9.4.3. Products
- 9.4.4. Recent Developments
9.5. Depomed
- 9.5.1. Company Overview
- 9.5.2. Company Revenue
- 9.5.3. Products
- 9.5.4. Recent Developments
9.6. Corium International Inc.
- 9.6.1. Company Overview
- 9.6.2. Company Revenue
- 9.6.3. Products
- 9.6.4. Recent Developments
9.7. Collegium Pharmaceutical
- 9.7.1. Company Overview
- 9.7.2. Company Revenue
- 9.7.3. Products
- 9.7.4. Recent Developments
9.8. GlaxoSmithKline
- 9.8.1. Company Overview
- 9.8.2. Company Revenue
- 9.8.3. Products
- 9.8.4. Recent Developments